New Zealand conservationists have launched a proactive vaccination campaign for endangered native birds, including the kākāpō, following the detection of highly pathogenic avian influenza (H5) in a seabird on Wellington’s Petone Beach. The Department of Conservation (DOC) is prioritizing core breeding populations to safeguard species such as the kākāpō, takahē, and black stilt against a potential outbreak, according to DOC officials.
Vaccinating Kākāpō Against Avian Influenza
The DOC vaccination strategy focuses on Whenua Hou/Codfish Island, a primary habitat for the kākāpō. According to DOC kākāpō vet Lydia Udstrom, the vaccination effort is a world-first preventative measure taken before the virus spreads widely through the country. The program targets approximately 70 long-term resident birds on the island, as these individuals face the highest exposure risk from migratory seabirds that may carry the virus.
The vaccination process involves two injections administered 3–5 weeks apart. This dual-dose approach is designed to trigger an initial antibody response followed by a long-term immune boost. To maintain a baseline for scientific monitoring, the DOC plans to leave a small number of birds unvaccinated. This strategy allows researchers to measure natural immunity and detect potential exposure through future blood sampling.
Did you know?
The current breeding season has been the most successful on record for the kākāpō. A total of 90 chicks were produced in a single season—a milestone that previously took the recovery program 16 years to achieve.
Comparing Risk Profiles: Kākāpō vs. Poultry
While the DOC focuses on native species, there is ongoing debate regarding the protection of domestic poultry. Melvin Pike, president of the Wairarapa Poultry and Pigeon Club, has advocated for expanding vaccination access to rare poultry breeds, noting that losses for these small-scale breeders would be significant.
Chief veterinary officer Dr. Mary van Andel cited two primary concerns:
- Trade Restrictions: Export markets may reject goods from countries that allow H5 bird flu vaccination.
- Diagnostic Challenges: Vaccinated birds can potentially mask the presence of the virus, complicating efforts to distinguish between immunized animals and those carrying the infection.
Long-term Outlook for New Zealand Wildlife
Conservation experts expect the virus to eventually become endemic once it establishes a foothold in the wild population. The immediate goal for agencies like the DOC is to shield critical breeding populations during the anticipated “first wave” of the disease. By securing these populations now, officials hope to provide native species the time needed to develop natural resilience to the virus.
The program also leverages data from a vaccine trial conducted two years ago. Researchers are currently providing booster shots to eight birds that participated in that initial study, which will offer crucial insights into the duration of vaccine-induced immunity in kākāpō.
Frequently Asked Questions
Why are only some kākāpō being vaccinated?
The DOC is targeting birds that reside long-term on Whenua Hou to maximize protection for the most vulnerable populations, while leaving a small control group to help monitor natural exposure and immunity levels.
Is bird flu currently widespread in New Zealand?
As of the most recent reports, the virus was identified in a single seabird found on Petone Beach. Conservation efforts are currently preventative.
Why isn’t the vaccine used for commercial chickens?
According to Dr. Mary van Andel, vaccination can interfere with international trade agreements and make it difficult for diagnostic tests to accurately identify infected birds.
For more updates on the kākāpō breeding season and conservation status, listen to the Kākāpō Files II podcast. Have questions about how these conservation efforts impact local wildlife? Share your thoughts in the comments below.
Related reading